Works matching IS 22965270 AND DT 2025 AND VI 48


Results: 58
    1

    Front & Back Matter.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 6, p. 1, doi. 10.1159/000546849
    Publication type:
    Article
    2

    PharmaNews.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 6, p. 396, doi. 10.1159/000546474
    Publication type:
    Article
    3

    PharmaNews.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 6, p. 395, doi. 10.1159/000546473
    Publication type:
    Article
    4
    5
    6

    Society Bulletins.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 6, p. 400, doi. 10.1159/000546409
    Publication type:
    Article
    7
    8
    9
    10
    11

    Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance?

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 6, p. 372, doi. 10.1159/000544838
    By:
    • Pfister, Kerstin;
    • Schäffler, Henning;
    • Huesmann, Sophia;
    • Heublein, Sabine;
    • Braun, Tatjana;
    • Lukac, Stefan;
    • Veselinovic, Kristina;
    • Mergel, Franziska;
    • Friedl, Thomas W.P.;
    • Rack, Brigitte;
    • Janni, Wolfgang;
    • Fink, Angelina
    Publication type:
    Article
    12
    13
    14
    15

    Front & Back Matter.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 5, p. 1, doi. 10.1159/000546291
    Publication type:
    Article
    16

    PharmaNews.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 5, p. 318, doi. 10.1159/000545951
    Publication type:
    Article
    17
    18
    19

    PharmaNews.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 5, p. 317, doi. 10.1159/000545811
    Publication type:
    Article
    20

    Society Bulletins.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 5, p. 320, doi. 10.1159/000545757
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Front & Back Matter.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 4, p. 1, doi. 10.1159/000545738
    Publication type:
    Article
    28

    PharmaNews.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 4, p. 228, doi. 10.1159/000545273
    Publication type:
    Article
    29

    Society Bulletins.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 4, p. 236, doi. 10.1159/000545238
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    Front & Back Matter.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 3, p. 1, doi. 10.1159/000545057
    Publication type:
    Article
    38
    39
    40

    PharmaNews.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 3, p. 152, doi. 10.1159/000544573
    Publication type:
    Article
    41

    Society Bulletins.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 3, p. 156, doi. 10.1159/000544116
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Prognostic Significance of HER2 Positivity in Endometrium Cancer.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 3, p. 75, doi. 10.1159/000542900
    By:
    • Sekmek, Serhat;
    • Bayram, Dogan;
    • Karahan, Irfan;
    • Seven, Ismet;
    • Perkin, Perihan;
    • Muftuoglu, Kamil Hakan;
    • Bal, Oznur;
    • Yalcin, Bulent;
    • Uncu, Dogan;
    • Algin, Efnan
    Publication type:
    Article
    48
    49

    Front & Back Matter.

    Published in:
    Oncology Research & Treatment, 2025, v. 48, n. 1/2, p. 1, doi. 10.1159/000544084
    Publication type:
    Article
    50